Secondary prevention: Where we are
- PMID: 28618902
- DOI: 10.1177/2047487317704978
Secondary prevention: Where we are
Abstract
The Sixth Joint Task Force of the European Society of Cardiology (ESC) and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Guidelines have been published in 2016: greater emphasis has been placed on a population-based approach, on disease-specific interventions and on female-specific conditions, younger individuals and ethnic minorities. The ESC guidelines underscore that a lifetime approach to cardiovascular risk is important as both risk and prevention are dynamic and continuous. The guidelines can assist healthcare professionals, patients, and are valuable for the healthcare system but implementation of secondary cardiovascular disease prevention is far from optimal. Although there is no single way to ensure the use of guidelines in practice, multifaceted interventions based on known barriers are most appropriate. Essential components for implementation are: (a) taking action; (b) strengthening capacity; (c) evaluating impact; (d) advancing policy; and (e) engaging in regional and global partnerships. The strategy depends on a balanced investment in all available intervention approaches, from policy and environmental changes designed to prevent risk factors to assurance of quality care for individuals with cardiovascular disease. Our greatest challenges represent our greatest opportunities.
Keywords: Cardiovascular disease; cardiovascular prevention.
Similar articles
-
Who needs secondary prevention?Eur J Prev Cardiol. 2017 Jun;24(3_suppl):8-13. doi: 10.1177/2047487317706112. Eur J Prev Cardiol. 2017. PMID: 28618916 Review.
-
Planning secondary prevention: Room for improvement.Eur J Prev Cardiol. 2017 Jun;24(3_suppl):22-28. doi: 10.1177/2047487317704954. Eur J Prev Cardiol. 2017. PMID: 28618903 Review.
-
Improving adherence to medication for secondary cardiovascular disease prevention.Eur J Prev Cardiol. 2017 Jun;24(3_suppl):29-35. doi: 10.1177/2047487317708145. Eur J Prev Cardiol. 2017. PMID: 28618909 Review.
-
Joint ESC/EACTS guidelines on myocardial revascularization.J Cardiovasc Med (Hagerstown). 2011 Apr;12(4):264-7. doi: 10.2459/JCM.0b013e328344e647. J Cardiovasc Med (Hagerstown). 2011. PMID: 21372739
-
Secondary prevention and cardiovascular care across Europe: A survey of European Society of Cardiology members' views.Eur J Cardiovasc Nurs. 2020 Mar;19(3):201-211. doi: 10.1177/1474515119877999. Epub 2019 Sep 27. Eur J Cardiovasc Nurs. 2020. PMID: 31560214
Cited by
-
Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data.JMIR Med Inform. 2020 Apr 2;8(4):e16400. doi: 10.2196/16400. JMIR Med Inform. 2020. PMID: 32238333 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources